A few things I gleaned from listening to the Q & A in the CureSHANK webinar this morning:
- The dose used in the trial (which is the same dose that will be used going forward) represents, for a 25kg patient, the equivalent of 5cc (1 teaspoon), taken twice daily.
- While an open label trial design was used in the Phase 2 study, it is expected that Phase 3 will be placebo-controlled.
- Safety was the broad reason for the exclusion of 5 patients after screening.
- Participants in the Phase 3 trial will be excluded from the pivotal Phase 3 trial as neither they nor their parents will be treatment- naïve. However, it is hoped that they can be included in the Phase 3 open label extension component of the trial.
- While not yet decided, it is probable that the pivotal trial will be restricted to the same age group as the Phase 2 trial (3-12 years). However, the company remains committed to extending treatment to all age groups and an additional trial in adolescents is a possibility.
- Geography for the trial is still to be determined.
- The last question was whether it was possible that NNZ-2591 might be applicable to syndromes other than PMS. The founder of CureSHANK was thrilled to hear that NNZ-2591 was being tested in other indications as well and might potentially be a therapeutic used across multiple neurodevelopmental rare diseases.
- Forums
- ASX - By Stock
- NEU
- Ann: 2023 Results webinar
Ann: 2023 Results webinar, page-125
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.95 |
Change
0.890(4.67%) |
Mkt cap ! $2.433B |
Open | High | Low | Value | Volume |
$19.58 | $19.95 | $19.47 | $1.020M | 51.93K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 147 | $19.95 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.98 | 20 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 138 | 19.770 |
3 | 167 | 19.760 |
3 | 189 | 19.750 |
4 | 272 | 19.740 |
1 | 80 | 19.730 |
Price($) | Vol. | No. |
---|---|---|
19.790 | 3106 | 8 |
19.800 | 2026 | 3 |
19.810 | 103 | 2 |
19.820 | 220 | 2 |
19.830 | 643 | 3 |
Last trade - 10.29am 14/05/2024 (20 minute delay) ? |
|
|||||
Last
$19.98 |
  |
Change
0.890 ( 4.53 %) |
|||
Open | High | Low | Volume | ||
$19.56 | $20.08 | $19.53 | 15124 | ||
Last updated 10.49am 14/05/2024 ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MGU
MAGNUM MINING AND EXPLORATION LIMITED
Neil Goodman, MD
Neil Goodman
MD
SPONSORED BY The Market Online